0001562180-17-000878.txt : 20170223
0001562180-17-000878.hdr.sgml : 20170223
20170223160140
ACCESSION NUMBER: 0001562180-17-000878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170221
FILED AS OF DATE: 20170223
DATE AS OF CHANGE: 20170223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amello Jason
CENTRAL INDEX KEY: 0001451805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 17632395
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 01824
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-02-21
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001451805
Amello Jason
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
SVP, CFO & Treasurer
Common Stock
2017-02-21
4
A
false
30000.00
0.00
A
65637.00
D
Stock Option (Right to buy)
0.00
2017-02-21
4
A
false
47500.00
10.14
A
2027-02-21
Common Stock
47500.00
47500.00
D
The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date.
The total amount of beneficial securities owned includes 1,500 shares of stock purchased on June 30, 2016 at $6.35 per share and 807 shares of stock purchased on December 31, 2016 at $6.48 per share in connection with the Issuer's Employee Stock Purchase Plan.
25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.
Nicole R. Hadas, attorney-in-fact for Jason A. Amello
2017-02-23